Appeal For Covid Drug Trial Participants
As the Covid-19 situation gradually moves from a pandemic to what most experts believe will be an endemic situation, the methods of treating the disease are also shifting.
Read MoreAs the Covid-19 situation gradually moves from a pandemic to what most experts believe will be an endemic situation, the methods of treating the disease are also shifting.
Read MoreIn a milestone achievement for xenotransplantation, a man with terminal heart disease received the first-ever genetically engineered heart transplant from a non-human donor.
Read MoreHere is the evolution of wearable health technology and the origins of the technologies that make the field possible.
Read MoreResearchers at the Beth Israel Deaconess Medical Centre (BIDMC) in Boston studied 22,000 reports of adverse reactions after a real Covid jab, compared with a similar number who had the placebo.
Read MoreLife sciences talent and strategic consultancy RBW Consulting has announced that it is to create 25 new jobs after setting up a new office in Newcastle.
Read MoreThe Pharma Letter reports that the UK is being urged to work with its ‘science allies’ while developing its post-Brexit medicines regulations, or it faces being left behind the ABPI said.
Read MoreClinical cancer trial recruitment has plummeted by 60% during the Covid-19 pandemic, leading to fears […]
Read MoreThe UK government has made an extra £375m of funding available for research into neurodegenerative diseases, it announced in a recent press release.
Read MoreHere are some top tips to help boost recruitment in life sciences and help the industry evolve.
Read MoreThe government has revealed it is planning to speed up its booster vaccination drive, in a bid to get as many people triple-jabbed in the wake of the new Omicron variant arriving in the UK.
Read MoreThe phenomenon of ‘long Covid’ started to appear in the public consciousness last spring, with reported symptoms including severe fatigue, breathlessness, heart palpitations and other persistent symptoms.
Read MoreProfessor Sarah Gilbert has called on the scientific community and governments to turn their attention to tackling a dozen more diseases.
Read More